Drug makers are legally required to spend money telling you their products might lead to a series of horrifying side effects, up to and including death.
Needless to say, for the pharmaceutical industry, this presents a communications challenge.
What is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Even when they do present the possible adverse effects they use indirection as much as possible. A good example is the DTC ad for one of the erectile dysfunction drugs. The ad talks about “if you experience loss of hearing or vision see a doctor right away.” Would it kill them to say “if you go deaf or blind see a doctor right away?”